Table 1.
Entry | Y | Z | Yield[a] | Yield[b] | Inhibition [%] of | Ki AT2R [μm] | |||
---|---|---|---|---|---|---|---|---|---|
X=tBu | X=H | [125I]CGP binding | Human | Human | Pig | ||||
1 μm | 10 μm | [125I]CGP | [125I]Sarile | [125I]Ang II | |||||
1 | H | 78 % 9 | 21 % 37[e] | 6 | 10 | ||||
2 | H | 66 % 10 | 56 % 38[e] | 3 | 11 | ||||
3 | H | 70 % 11 | 75 % 39[e] | 4 | 13 | ||||
4 | H | 76 % 12 | 82 % 40[e] | –[c] | 12 | ||||
5 | H | 57 % 13 | 68 % 41[e] | 5 | 6 | ||||
6 | H | 24 % 14 | 73 % 42[e] | 6 | 23 | 22.0 | 19.4 | ||
7 | H | 42 % 15 | 69 % 43[e] | 2 | 4 | ||||
8 | H | 75 % 16 | 65 % 44[e] | 6 | 32 | 9.0 | 11.0 | ||
9 | H | 85 % 17 | 62 % 45[e] | 6 | 7 | ||||
10 | H | 55 % 18 | 95 % 46[e] | 6 | 7 | ||||
11 | H | 14 % 19 | 96 % 47[e] | 13 | 43 | 7.5 | 9.6 | ||
12 | H | 43 % 20 | 64 % 48 | 14[d] | 31[d] | 11.0 | 3.1 | ||
13 | H | 70 % 21 | 89 % 49 | –[c] | 12 | ||||
14 | Me | 85 % 22 | 47 % 50[e] | –[c] | 7 | ||||
15 | Me | 75 % 23 | 77 % 51[e] | 7 | 13 | ||||
16 | Me | 53 % 24 | 75 % 52[e] | 4 | 7 | ||||
17 | Me | 22 % 25 | 72 % 53[e] | 28 | 62 | 2.4 | 2.6 | ||
18 | Me | 30 % 26 | 84 % 54[e] | 1 | 18 | ||||
19 | Me | 45 % 27 | 68 % 55[e] | 16 | 34 | 7.6 | 11.2 | ||
20 | Me | 83 % 28 | 65 % 56[e] | 1 | 7 | ||||
21 | Me | 74 % 29 | 75 % 57[e] | 1 | 4 | ||||
22 | Me | 22 % 30 | 82 % 58[e] | 18 | 62 | 2.5 | 2.3 | ||
23 | Me | 48 % 31 | 71 % 59 | 4[d] | 54[d] | 3.4 | 1.5 | ||
24 | Me | 75 % 32 | 76 % 60 | –[c] | 6 | ||||
25 | Et | 48 % 33 | 58 % 61 | 6[d] | 29[d] | 10.0 | |||
26 | Et | 66 % 34 | 49 % 62 | –[c] | 26[d] | 16.0 | |||
27 | Et | 50 % 35 | 52 % 63 | 11[d] | 40[d] | 8.3 | |||
28 | Et | 62 % 36 | 46 % 64 | 11[d] | 50[d] | 4.4 | |||
29 | H | 68 % 65 | 74 % 68 | –[c] | –[c] | n.c.[f] | |||
30 | H | 73 % 66 | 88 % 69 | –[c] | 7[d] | >100 | |||
31 | H | 16 % 67 | 57 % 70 | –[c] | 5[d] | 35.0 | |||
Compound | |||||||||
32 | E | 110.0 | 47.0 | 0.0166 | |||||
33 | F | 63.0 | 0.0370 | ||||||
34 | C | 0.025 | 0.0005 | ||||||
35 | B (Ang IV) | 0.035 | 0.0077 | ||||||
36 | A (Ang II) | 0.044×10−3 | 0.0028 | 0.0003 | |||||
37 | D (C21/M024) | 0.0098 | 0.0076 | 0.0004 |
Isolated yield after the aminocarbonylation reaction, >95 % purity.
Isolated yield after the deprotection, >95 % purity.
Not active.
Compound not included in the affinity screen, value taken from Ki determination.
Evaluated for AT1R affinity, none of the compounds exhibited any binding.
Not calculable—less than 25 % displacement at highest concentration.